The study found that patients who received radiation treatment for prostate had a 68 percent chance of survival, compared to 51 percent who did not receive any treatment.
The study was presented at the 2010 American Urology Association’s annual meeting.
Read more about the Henry Ford Hospital prostate cancer study.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.